Comparative Effects of Glucagon-Like Peptide-1 Receptors Agonists, 4-Dipeptidyl Peptidase Inhibitors, and Metformin on Metabolic Syndrome
Cristina Bouzas,Rosario Pastor,Silvia Garcia,Margalida Monserrat-Mesquida,Miguel Angel Martinez-Gonzalez.,Jordi Salas-Salvado,Dolores Corella,Albert Goday,J. Alfredo Martinez, Angel M. Alonso-Gomez,Olga Fernandez-Barcelo,Jesus Vioque,Dora Romaguera,Jose Lopez-Miranda,Ramon Estruch,Francisco J. Tinahones,Jose Lapetra,Lluis Serra-Majema,Blanca Riquelme-Gallegop,Vicente Martin-Sanchez,Xavier Pinto,Miguel Delgado-Rodriguez,Pilar Matia,Josep Vidal, Jersy-Jair Cardenas-Salas,Lidia Daimiel,Emilio Ros,Estefania Toledo, Josep M. Manzanares,Inmaculada Gonzalez-Monge,Miguel-Angel Munoz,Diego Martinez-Urbistondo,Lucas Tojal-Sierra,Carlos Munoz-Bravoaf, Salvador Miralles-Gisbert,Marian Martin,Antonio Garcia-Rios,Sara Castro-Barquero,Jose Carlos Fernandez-Garcia, Jose Manuel Santos-Lozano,F. Javier Basterra-Gortari,Liliana Gutierrez-Carrasquilla,Patricia Guillem-Saiz, Alba Satorres,Itziar Abete,Carolina Sorto-Sanchez,Javier Diez-Espino,Nancy Babio,Montse Fito,Josep A. Tur BIOMEDICINE & PHARMACOTHERAPY（2023）
Key words
Metabolic syndrome,Glucagon-like peptide 1 agonists,GLP-1RA,4-dipeptidyl peptidase inhibitors,DPP-4I
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper